Inventor · disambiguated record
Jacqueline Wyatt
Also filed as: WYATT JACQUELINE · WYATT JACQUELINE R
53 granted patents·61 pending applications·2,400 citations·filing 1992–2011
99Inventor score
Top patents by PatentIndex Score
114 records- 0199US6365354B1Antisense modulation of lysophospholipase I expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 2, 2002·366 cites·26 claims
- 0299US6287860B1Antisense inhibition of MEKK2 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 11, 2001·334 cites·14 claims
- 0398US6210892B1Alteration of cellular behavior by antisense modulation of mRNA processingISIS PHARMACEUTICALS INC·Filed 1999·Granted Apr 3, 2001·358 cites·31 claims
- 0497US6444464B1Antisense modulation of E2F transcription factor 2 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 3, 2002·115 cites·13 claims
- 0596US6261840B1Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 17, 2001·98 cites·15 claims
- 0695US7563884B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2004·Granted Jul 21, 2009·67 cites·28 claims
- 0795US7321828B2System of components for preparing oligonucleotidesISIS PHARMACEUTICALS INC·Filed 1998·Granted Jan 22, 2008·216 cites·4 claims
- 0894US5523389AInhibitors of human immunodeficiency virusISIS PHARMACEUTICALS INC·Filed 1993·Granted Jun 4, 1996·73 cites·1 claims
- 0993US6265216B1Antisense modulation of cot oncogene expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 24, 2001·29 cites·14 claims
- 1093US5925732AChemical reaction apparatus for performing multiple reaction on a surface and collecting the productISIS PHARMACEUTICALS INC·Filed 1997·Granted Jul 20, 1999·99 cites·11 claims
- 1192US6329203B1Antisense modulation of glioma-associated oncogene-1 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Dec 11, 2001·32 cites·13 claims
- 1292US5952490AOligonucleotides having a conserved G4 core sequenceISIS PHARMACEUTICALS INC·Filed 1993·Granted Sep 14, 1999·69 cites·27 claims
- 1390US6379960B1Antisense modulation of damage-specific DNA binding protein 2, p48 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 30, 2002·32 cites·26 claims
- 1490US5514577AOligonucleotide therapies for modulating the effects of herpes virusesISIS PHARMACEUTICALS INC·Filed 1993·Granted May 7, 1996·153 cites·2 claims
- 1589US6455307B1Antisense modulation of casein kinase 2-alpha prime expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Sep 24, 2002·25 cites·26 claims
- 1688US6602857B1Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 5, 2003·32 cites·72 claims
- 1787US6444465B1Antinsense modulation of Her-1 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Sep 3, 2002·13 cites·26 claims
- 1886US6503754B1Antisense modulation of BH3 interacting domain death agonist expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jan 7, 2003·17 cites·26 claims
- 1985US6440738B1Antisense modulation of casein kinase 2-beta expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Aug 27, 2002·12 cites·26 claims
- 2085US6372433B1Antisense modulation of inhibitor of DNA binding-1 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 16, 2002·22 cites·13 claims
- 2184US8017760B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2008·Granted Sep 13, 2011·4 cites·13 claims
- 2284US7179796B2Antisense modulation of PTP1B expressionISIS PHARMACEUTICALS INC·Filed 2003·Granted Feb 20, 2007·12 cites·3 claims
- 2384US6271030B1Antisense inhibition of C/EBP beta expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Aug 7, 2001·17 cites·13 claims
- 2483US6187545B1Antisense modulation of pepck-cytosolic expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Feb 13, 2001·17 cites·10 claims
- 2582US6498035B1Antisense modulation of MEKK3 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Dec 24, 2002·10 cites·26 claims
- 2681US6602713B1Antisense modulation of protein phosphatase 2 catalytic subunit beta expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Aug 5, 2003·7 cites·26 claims
- 2780US6323029B1Antisense modulation of glycogen synthase kinase 3 beta expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Nov 27, 2001·12 cites·26 claims
- 2880US6268151B1Antisense modulation of macrophage migration inhibitory factor expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 31, 2001·12 cites·13 claims
- 2979US6306655B1Antisense inhibition of C/EBP alpha expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Oct 23, 2001·12 cites·13 claims
- 3078US6906186B1Antisense modulation of polo-like kinase expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Jun 14, 2005·5 cites·12 claims
- 3178US6387699B1Antisense inhibition of A20 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted May 14, 2002·4 cites·26 claims
- 3277US6306606B1Antisense modulation of MP-1 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Oct 23, 2001·4 cites·13 claims
- 3376US6503756B1Antisense modulation of syntaxin 4 interacting protein expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jan 7, 2003·4 cites·10 claims
- 3475US6316259B1Antisense inhibition of glycogen synthase kinase 3 alpha expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Nov 13, 2001·7 cites·26 claims
- 3575US6277334B1Chemical synthesis apparatus employing a droplet generatorISIS PHARMACEUTICALS INC·Filed 1999·Granted Aug 21, 2001·28 cites·17 claims
- 3673US6165791AAntisense inhibition of E2F transcription factor 3 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Dec 26, 2000·3 cites·18 claims
- 3772US5698391AMethods for synthetic unrandomization of oligomer fragmentsISIS PHARMACEUTICALS INC·Filed 1994·Granted Dec 16, 1997·36 cites·80 claims
- 3870US6255110B1Antisense modulation of ARA70 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 3, 2001·1 cites·13 claims
- 3970US2004197814A1System of components for preparing oligonucleotidesFiled 2004·Application pending·0 cites
- 4069US6465250B1Antisense modulation of protein phosphatase 2 catalytic subunit alpha expressionISIS PHARMACEUTICALS INC·Filed 2001·Granted Oct 15, 2002·1 cites·26 claims
- 4169US6426188B1Antisense modulation of phosphorylase kinase alpha 1 expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Jul 30, 2002·1 cites·26 claims
- 4269US6368856B1Antisense inhibition of Phosphorylase kinase beta expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 9, 2002·1 cites·26 claims
- 4368US7592440B2Methods of obtaining active antisense compoundsISIS PHARMACEUTICALS INC·Filed 2003·Granted Sep 22, 2009·2 cites·8 claims
- 4468US6716975B2Antisense modulation of EDG1 expressionISIS PHARMACEUTICALS INC·Filed 2002·Granted Apr 6, 2004·2 cites·10 claims
- 4568US2005033524A1Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulationFiled 2003·Application pending·0 cites
- 4667US6653133B1Antisense modulation of Fas mediated signalingISIS PHARMACEUTICALS INC·Filed 2000·Granted Nov 25, 2003·2 cites·13 claims
- 4767US6475797B1Antisense modulation of SR-CYP expressionISIS PHARMACEUTICALS INC·Filed 2000·Granted Nov 5, 2002·1 cites·26 claims
- 4866US8202982B2Methods of obtaining active antisense compoundsFREIER SUSAN M·Filed 2009·Granted Jun 19, 2012·0 cites·5 claims
- 4964US6558633B1Chemical reaction apparatus and methodsISIS PHARMACEUTICALS INC·Filed 1994·Granted May 6, 2003·10 cites·2 claims
- 5064US2006069518A1Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulationISIS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
Showing the top 50 of 114 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jacqueline Wyatt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →